In the recent interview Chief Minister of Kerala has confirmed that the Russian authorities are talking with the Kerala government to set up the manufacturing plant for the Sputnik vaccine. These vaccines will be further developed by one of the most renowned plants, Gamaleya centre. Sputnik vaccine is a Russian vaccine, and it is used in nearly 70 nations across the world. Its adoption had been slowed by controversies and questions over rare side effects affecting the patients after taking it. The World Health Organization does not yet approve the vaccine.
This Russian vaccine has been the subject of fascination and controversy since the release authorized its use last year in the country, and early-stage trial results were even published to the world. Evidence from Russia and many other countries using the vaccine now suggests that it is safe and effective. Still, significant questions remain about the quality of surveillance for possible rare side effects that might cause after taking the vaccine.
Sputnik V was the first covid vaccine to be registered for use in any nation, and the vaccine was approved in 67 countries, including India. But its one sibling dose Sputnik Light has yet to receive approval for emergency use from the European Medicines Agency or the World Health Organization. This is because support by the WHO is crucial for widespread distribution through the covid-19 Vaccines global access initiative, which provides doses for lower-income nations free of cost. This vaccine was developed by scientists at the Gamaleya National Research Center of Epidemiology and Microbiology in Moscow. The vaccine was first authorized for use only by the Russian Ministry more than a month before phase I and II trial results were published before the phase III trial had even begun for the dose.